Dr Lucy Burr

Academic Title-Senior Lecturer

Mater Research Institute-UQ
Faculty of Medicine

Academic Title-Senior Lecturer

Mater Clinical Unit
Faculty of Medicine

Overview

Dr Lucy Burr is the Cystic Fibrosis (CF) Centre Director at the Mater Hospital, Brisbane, where she practices as a full time Respiratory and Sleep Physician. She is also a Senior Lecturer at the University of Queensland and has an active role in teaching medical students. Lucy leads the Cystic Fibrosis Research group in the Mater Respiratory, Infectious Diseases and Thoracic Oncology (RIO) Research unit, with a team of 8 clinical and scientific researchers.

Lucy is the author of over 14 scientific publications with her research currently focused on improving the care and outcomes of patients with both Cystic Fibrosis and bronchiectasis — multi-system inflammatory diseases with prominent effects on the lung. She has been interested in bronchiectasis since her PhD, where she investigated the impact of infections caused by the bacterium P. aeruginosa in individuals affected by this disease. A major outcome of her research has been the demonstration of the role of manipulating bacterial communication in the treatment of bronchiectasis.

Her group is currently expanding this research by investigating the microbiological impact of treatments and disease in Cystic and non-Cystic Fibrosis bronchiectasis. This research is particularly focussed on assessing the impact of intestinal dysbiosis and the effect of altering the gut microbiome to influence and improve pulmonary outcomes.

Lucy trained as a medical doctor in the UK at Kings College London, emigrating to Australia in 2004. She has worked as a doctor in the Northern Territory and South East Queensland, settling in Brisbane where she completed her specialist training in Respiratory and Sleep medicine, and PhD studies with the University of Queensland. Lucy is currently the Deputy Convenor of the Respiratory Infectious Diseases Special Interest Group of the Thoracic Society of Australia and New Zealand, and a core member of the Australian Bronchiectasis Consortium. She is a current Betty McGrath Research Fellow.

Qualifications

  • Fellow of the RACP, RACP
  • Doctor of Philosophy, The University of Queensland

Publications

View all Publications

Publications

Journal Article

Conference Publication

  • Taylor, S., Rogers, G., Chen, A., Burr, L., McGuckin, M. and Serisier, D. (2015). Collagen protease levels vary with airway microbiota composition and lung function in bronchiectasis. In: Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting, Gold Coast, Australia, (127-127). 27 March – 1 April 2015. doi:10.1111/resp.12495_14

  • Scoleri, G., Leong, L., Burr, L., Choo, J., Thomson, R., Serisier, D. and Rogers, G. (2015). Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavage. In: Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Gold Coast, Australia, (28-28). 27 March – 1 April 2015. doi:10.1111/resp.12494_8

  • Burr, L., Rogers, G., Taylor, S., McGuckin, M. and Serisier, D. (2015). Sub inhibitory erythromycin reduces the expression of key P. aeruginosa virulence determinants in vitro. In: Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting, Gold Coast, Australia, (127-127). 27 March – 1 April 2015. doi:10.1111/resp.12495_14

  • Chen, A., Martin, M., Lourie, R., Burr, L., Hasnain, S., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content. In: Abstracts of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014 Annual Scientific Meeting. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, (88-88). 4-9 April 2014. doi:10.1111/resp.12263_6

  • Rogers, G., Chen, A., Burr, L. and Serisier, D. (2014). Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis Bronchiectasis. In: Abstracts of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014 Annual Scientific Meeting. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, (30-30). 4-9 April 2014. doi:10.1111/resp.12262_10

  • Chen, A., Lourie, R., Martin, M., Burr, L., Hasnain, S., Fantino, E., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis. In: Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2014 Annual Scientific Meetings, Adelaide Australia, (87-87). 4-9 April 2014. doi:10.1111/resp.12263_6

  • Visser, S., Burr, L., Rogers, G. and Serisier, D. (2014). Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot Study. In: Abstracts of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014 Annual Scientific Meeting. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, (112-112). 4-9 April 2014. doi:10.1111/resp.12263_10